| BCBS Louisiana | Transcatheter Arterial Chemoembolization (TACE) to Treat Primary or Metastatic Liver Malignancies | 2026-06-01 |
| BCBS Louisiana | Vesicular Monoamine Transporter Type 2 Inhibitors: deutetrabenazine (Austedo®, Austedo® XR), tetrabenazine (Xenazine®, generics), valbenazine (Ingrezza™) | 2026-06-01 |
| BCBS Louisiana | Angiotensin Converting Enzyme-Inhibitors and Angiotensin Converting Enzyme-Inhibitor Combination Drugs | 2026-06-01 |
| BCBS Louisiana | Select Ophthalmic Prostaglandin-Related Agents | 2026-06-01 |
| BCBS Louisiana | tasimelteon (Hetlioz®, Hetlioz LQ™, generics) | 2026-06-01 |
| BCBS Louisiana | Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) Inhibitors (alirocumab [Praluent®], evolocumab [Repatha™]) | 2026-06-01 |
| BCBS Louisiana | dichlorphenamide (Keveyis™, generics) | 2026-06-01 |
| BCBS Louisiana | uridine triacetate (Xuriden™) | 2026-06-01 |
| BCBS Louisiana | sebelipase alfa (Kanuma™) | 2026-06-01 |
| BCBS Louisiana | prednisone delayed release tablet (Rayos®, generics) | 2026-06-01 |